Trademark: 97632833
Word
BIOLOGY42
Status
Pending
Status Code
681
Status Date
Monday, April 22, 2024
Serial Number
97632833
Mark Type
4
Filing Date
Friday, October 14, 2022
Published for Opposition
Tuesday, May 28, 2024

Trademark Owner History
Insilico Medicine IP Limited - Owner At Publication

Classifications
9 Computers, computer hardware and computer peripheral devices; downloadable mobile applications using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software using artificial intelligence for automated machine learning in the field of drug design and development; downloadable computer programs using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer programs using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded; data processing apparatus being data processors; Electronic card readers; data processing equipment, namely, scanners; Downloadable computer software using artificial intelligence for machine learning in the field of drug design and development; Downloadable data sets using artificial intelligence for automated machine learning in the field of drug design and development; Data sets using artificial intelligence for automated machine learning in the field of drug design and development recorded on computer media; downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded, for automated machine learning in the field of drug design and development; data processing apparatus, namely, data processors for automated machine learning in the field of drug design and development
42 Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product research and design relating thereto; artificial intelligence driven robotics drug discovery scientific laboratory services; design and development of computer hardware and software; Software as a service (SAAS) services featuring software for use in database management n the field of drug design and development; software development in the framework of software publishing; updating of computer software; Platform as a service (PAAS) featuring computer software platforms for use in database management in the field of drug design and development; development of computer platforms; computer system design; rental of computer software for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website-based indexes of information in the field of drug design and development for others using information technology services; computer programming; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; platform as a service (PaaS) featuring computer software platforms for use in database management for using artificial intelligence for automated machine learning in the field of drug design and development; research in the field of artificial intelligence; conversion of data or documents from physical to electronic media; conversion of computer programs and data, other than physical conversion; electronic data storage; computer programming service for data processing; providing medical and scientific research information; Providing a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; provision of scientific information in the fields of pharmaceutical research and development, drug discovery and medical and scientific research; computer software design; software as a service (SaaS) services featuring software for using artificial intelligence for automated machine learning in the field of drug design and development; platform as a service (PaaS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website based indexes of data and information for others using information technology; computer programming services; installation of computer software; installation, maintenance, and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of drug design and development; customizing computer software; custom design of computer software; developing customized software in the field of drug design and development

Trademark Events
May 20, 2023
Assigned To Examiner
Oct 18, 2022
New Application Entered
Oct 18, 2022
New Application Office Supplied Data Entered
Jun 7, 2023
Examiners Amendment -Written
Jun 7, 2023
Examiners Amendment E-Mailed
Jun 7, 2023
Notification Of Examiners Amendment E-Mailed
Jun 13, 2023
Assigned To Lie
Jun 13, 2023
Examiner's Amendment Entered
Jun 15, 2023
Approved For Pub - Principal Register
Jul 5, 2023
Notification Of Notice Of Publication E-Mailed
Jul 25, 2023
Published For Opposition
Jul 25, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 13, 2024
Teas Petition To Amend Basis Received
Sep 19, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 2, 2024
Assigned To Petition Staff
Apr 3, 2024
Petition To Director - Change Basis - Granted
Mar 19, 2024
Notice Of Allowance Cancelled
Apr 9, 2024
Case Returned To Examination
May 8, 2024
Notification Of Notice Of Publication E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24